Prelude Capital Management’s Vericel Corp VCEL Stock Holding History

Prelude Capital Management’s Portfolio VCEL Stock Details VCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-7,420	Closed	-$316K	–	1398
2025 Q2	$316K	Buy	+7,420	New	+$309K	0.03%	595
2020 Q1	–	Sell	-8,000	Closed	-$139K	–	2070
2019 Q4	$139K	Buy	+8,000	New	+$136K	0.01%	980
2019 Q2	–	Sell	-28,313	Closed	-$496K	–	2175
2019 Q1	$496K	Buy	28,313 +357	+1%	+$6.53K	0.03%	501
2018 Q4	$486K	Buy	27,956 +7,711	+38%	+$115K	0.03%	478
2018 Q3	$286K	Buy	20,245 +4,172	+26%	+$48.9K	0.02%	686
2018 Q2	$156K	Buy	16,073 +900	+6%	+$11.2K	0.01%	805
2018 Q1	$151K	Buy	+15,173	New	+$125K	0.01%	749

Other funds holding VCEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Prelude Capital Management's VCEL Position: Q3 2025 in Review

Prelude Capital Management sold out of Vericel Corp (VCEL) in Q3 2025, closing a stake of 7,420 shares — an estimated $316K sold.

Prelude Capital Management first reported a position in VCEL in Q1 2018 and held it in 7 quarters. The position peaked at $496K in Q1 2019. 249 funds tracked by Wall St. Rank hold VCEL as of Q3 2025.

Prelude Capital Management reported no remaining Vericel Corp position as of Q3 2025 after selling out during the quarter.
Prelude Capital Management sold 7,420 Vericel Corp shares in Q3 2025, an estimated $316K.
Prelude Capital Management first reported a position in Vericel Corp in Q1 2018 and held it in 7 quarters.
Prelude Capital Management's Vericel Corp position peaked at $496K in Q1 2019.
249 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2025.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.